linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
HFCL Ltd.
 
Source DateBoard Meeting DateDetails
09 May 202522 May 2025 Audited Results & Dividend
23 Jan 202503 Feb 2025 Quarterly Results
11 Oct 202421 Oct 2024 Quarterly Results
12 Jul 202424 Jul 2024 Quarterly Results
19 Apr 202403 May 2024 Audited Results & Dividend
16 Jan 202401 Feb 2024 Quarterly Results (Revised)
11 Jan 202425 Jan 2024 Quarterly Results
10 Oct 202319 Oct 2023 Quarterly Results
14 Jul 202326 Jul 2023 Quarterly Results
02 May 202308 May 2023 Final Dividend (Revised) & Audited Results
27 Apr 202309 May 2023 Audited Results
11 Jan 202323 Jan 2023 Quarterly Results
10 Oct 202218 Oct 2022 Quarterly Results
29 Aug 202202 Sep 2022 Inter-alia, to consider and evaluate the proposals for fund raising by way of issue of equity shares/ preference shares/ bonds/ debentures/ non-convertible debt instruments/ warrants/ any other securities, including through preferential issue on a private placement basis, qualified institutional placement, rights issue or any other methods or combination thereof, subject to approval from the shareholders in the ensuing annual general meeting and sanctions/approvals from the other regulatory/ governmental authorities, as may be required.
13 Jul 202222 Jul 2022 Quarterly Results
13 Apr 202229 Apr 2022 Dividend & Audited Results
07 Jan 202217 Jan 2022 Quarterly Results
30 Sep 202111 Oct 2021 Quarterly Results
30 Aug 202103 Sep 2021 HFCL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2021 ,inter alia, to consider and approve inter-alia, to consider and evaluate the proposals for fund raising by way of issue of equity shares/ preference shares/ bonds/ debentures/ non-convertible debt instruments/ equity shares/ warrants/ any other securities, including through preferential issue on a private placement basis, qualified institutional placement, rights issue or any other methods or combination thereof, subject to approval from the shareholders in the ensuing annual general meeting and sanctions/approvals from the other regulatory/ overnmental authorities, as may be required.
02 Jul 202112 Jul 2021 Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.